NFκB is a potent proinflammatory transcription factor that is elevated in the PD brain (29), has been proposed as a therapeutic target for PD (30), and induces the expression of TNF-α, IL-1β, and inducible nitric oxide synthase (iNOS) (31–33). The gene discussed is IL1B; the disease is Parkinson disease.